Characterization of the protein interactors of Plasmodium falciparum Hsp70 (PfHsp70-1): towards the development of small-molecule inhibitors of PfHsp70-1 chaperone function
Characterization of the protein interactors of Plasmodium falciparum Hsp70 (PfHsp70-1): towards the development of small-molecule inhibitors of PfHsp70-1 chaperone function
批准号:
68955586
负责人:
Professor Dr. Klaus Lingelbach (†)
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2009
资助国家:
德国
项目状态:
已结题
起止时间:
2008-12-31 至 2011-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Plasmodium falciparum is the causative agent of malaria tropica which is responsible for most of the deaths caused by malaria. The pathology of the disease is the result of parasite growth and replication within human erythrocytes. Within its host, the parasite is very well adapted to stress conditions such as high febrile temperatures; in fact several studies suggest that acute temperature increases augment parasite development and infectivity. The subject of this project is the P. falciparum heat shock protein 70-1 (PfHsp70-1) which is expressed throughout all intra-erythrocytic stages. Hsp70 proteins form a ubiquitous and conserved family of molecular chaperones whose main function is to ensure the correct folding of other protein substrates, usually in cooperation with other heat shock proteins. Although PfHsp70-1 has properties that are similar to mammalian Hsp70 (chaperone functions, increased levels under stress conditions), work in the South African laboratory have also revealed biochemically distinct properties. According to our working hypothesis, these distinct properties represent evolutionary adaptations to an intracellular and parasitic life. Therefore we aim to identify the functional partner proteins and substrate proteins of PfHsp70-1 to precisely define the parasite-specific functions of this protein. The ultimate aim is to use this information for the development of specific inhibitors as lead compounds for novel anti-malarial drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular interactions of PfHop as a target for anti-malarial drug development
-
批准号:215044407
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Professor Dr. Klaus Lingelbach (†)
-
依托单位:
Identification of proteins involved in the formation of Novel Permeation Pathways in the plasma membrane of the Plasmodium falciparum-infected erythrocyte
-
批准号:5434702
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Professor Dr. Klaus Lingelbach (†)
-
依托单位:
Structural requirements for protein transport across the vacuolar membrane of Plasmodium falciparum
-
批准号:5374421
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:Professor Dr. Klaus Lingelbach (†)
-
依托单位:
Koordination des SPP "Intrazelluläre Lebensformen"
-
批准号:5387999
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:Professor Dr. Klaus Lingelbach (†)
-
依托单位:
Aufklärung von Proteinfunktionen durch Transformation von Plasmodium falciparum
-
批准号:5095812
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:Professor Dr. Klaus Lingelbach (†)
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: